Skip to main content

Springer

Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance

No reviews yet
Product Code: 9781461476535
ISBN13: 9781461476535
Condition: New
$180.44

Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance

$180.44
 
​​​​The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of mAbs agains various cancer, gives the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.


Author: Benjamin Bonavida
Publisher: Springer
Publication Date: Aug 05, 2013
Number of Pages: 202 pages
Binding: Hardback or Cased Book
ISBN-10: 1461476534
ISBN-13: 9781461476535
 

Customer Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Faster Shipping

Delivery in 3-8 days

Easy Returns

14 days returns

Discount upto 30%

Monthly discount on books

Outstanding Customer Service

Support 24 hours a day